Description: Bortezomib in the Treatment of Multiple Myeloma, Hardcover by Ghobrial, Irene M. (EDT), ISBN 3764389478, ISBN-13 9783764389475, Like New Used, Free P&P in the UK Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promising anticancer drug targeting the proteasome. This proteasome inhibitor induces cell stress and apoptosis in the cancer cells. While multiple mechanisms are likely to be involved, proteasome inhibition may prevent the degradation of pro-apoptotic factors, permitting activation of programmed cell death in neoplastic cells dependent upon the suppression of proapoptotic monograph on bortezomib is a valuable source of information for researchers and clinicians from the fields of oncology and pharmacology, working either in academia or the pharmaceutical industry.
Price: 114.39 GBP
Location: Castle Donington
End Time: 2024-12-04T09:15:13.000Z
Shipping Cost: 20.05 GBP
Product Images
Item Specifics
Return postage will be paid by: Buyer
Returns Accepted: Returns Accepted
After receiving the item, your buyer should cancel the purchase within: 30 days
Book Title: Bortezomib in the Treatment of Multiple Myeloma
Number of Pages: 180 Pages
Publication Name: Bortezomib in the Treatment of Multiple Myeloma
Language: English
Publisher: Birkhauser Verlag A&G
Item Height: 235 mm
Subject: Medicine, Biology
Publication Year: 2010
Type: Textbook
Item Weight: 444 g
Author: Irene M. Ghobrial, Paul G. Richardson, Kenneth C. Anderson
Item Width: 155 mm
Series: Milestones in Drug Therapy
Format: Hardcover
